The global women’s health market size is projected to reach USD 41.05 billion by 2027, the market size was USD 35.02 billion in 2019, exhibiting a CAGR of 3.2% during the forecast period (2020-2027).
This information is published by Fortune Business Insights in its report, titled “Women’s Health Market Size, Share & COVID-19 Impact Analysis, By Component, By Application, By End-User, and Regional Forecast, 2020-2027.”
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/women-s-health-market-101847
The infection caused by the coronavirus, which has affected more men than women across the globe, has brought the issue of health of women in the spotlight. A UN policy brief released in April 2020 stated that women hold less secure jobs and earn lower wages, which makes them highly vulnerable to the adverse effects of this pandemic. More importantly, as the pandemic intensifies, women’s health will inevitably suffer. For example, in March 2020, the UNESCO estimated that the 1.5 billion children worldwide are out of school and this puts female students at a heightened risk of sexual abuse, genital mutilation, and early marriage. With governments recognizing the significance of maintaining women’s health, the demand for modern, efficient female healthcare products is expected to rise amid this current crisis.
Driving Factor
Increasing Prevalence of Women-centric Diseases to Aid Growth
A leading factor aiding the women’s health market growth is the rising incidence of women-specific diseases and disorders around the globe. For example, the 2018 GLOBOCAN report by the International Agency for Research on Cancer (IARC) revealed that female breast cancer diagnoses stood at 2.1 million in 2018, accounting for approximately 11.6% of the total global cancer burden. Further, female breast cancer was the fifth leading cause of death, contributing to 6.6% of the total global deaths in 2018. Another prime example is osteoporosis in women, a disease that generally afflicts menopausal women, causing reduction in bone density. The National Osteoporosis Foundation, for example, estimates that 20% of Caucasian women aged 50 and above have osteoporosis. As a result of their complex internal body dynamics, management of women’s health, especially post-pregnancy and post-menopause, when hormone imbalances are known to occur, requires high level of efficiency and accuracy. Products designed to facilitate effective management of women-centric diseases will, thus, play a crucial in augmenting this market in the forthcoming years.
Quick Buy – Women’s Health Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101847
As per the report, the global market value stood at USD 35.02 billion. The salient features of the report include:
- In-depth evaluation of the market trends, drivers, and restraints;
- Careful examination of the different market segments;
- Microscopic assessment of the regional and competitive developments influencing the market growth; and
- Broad-based understanding of the overall industry outlook and opportunities.
Regional Insights
Robust Spending on Women’s Healthcare to Stoke Market Growth in North America
North America is expected to emerge as a major revenue generator for this market during the forecast period, having registered a market size of USD 18.00 billion in 2019. The primary reason for the region’s dominance in the market share is the large amount of funds allocated to enhance women’s healthcare across the US and Canada. This is a result of the spreading awareness about health issues and the growing prevalence of women-specific diseases in the region.
Improving healthcare infrastructure, especially in Eastern European countries, is anticipated to bolster Europe’s position as the second-largest region in this market. Asia Pacific is expected to grow at the highest CAGR on account of the rising awareness about the importance women health.
List of Key Companies Profiled in this Market Report:
- Agile Therapeutics (New Jersey, USA)
- LUPIN (Mumbai, India)
- Merck & Co., Inc. (New Jersey, United States)
- Amgen Inc. (California, United States)
- Bayer AG (Leverkusen, Germany)
- AstraZeneca (Cambridge, UK)
- Eli Lilly and Company (Indiana, United States)
- Novartis AG (Basel, Switzerland)
- Pfizer Inc. (New York, United States)
Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/women-s-health-market-101847
Major Points in TOC:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Women Related Disorders, By Key Countries/Region
- New Product Launches
- Key Mergers, Acquisition, and Partnerships
- Key Industry Trends
- Impact of COVID-19 on Women’s Health Market
- Global Women’s Health Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Application
- Contraceptives
- Osteoporosis
- Menopause
- Infertility
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Women’s Health Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Application
- Contraceptives
- Osteoporosis
- Menopause
- Infertility
- Others
- Market Analysis – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market Analysis – By Country
- U.S.
- By Application
- Canada
- By Application
- U.S.
TOC Continued…..
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245